blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3289868

EP3289868 - NERVE-CELL CULTURING APPARATUS [Right-click to bookmark this link]
Former [2018/10]MODEL-ANIMAL FUNCTIONAL-IMPROVEMENT EVALUATION APPARATUS AND NERVE-CELL CULTURING APPARATUS
[2023/45]
StatusThe patent has been granted
Status updated on  22.12.2023
Database last updated on 02.11.2024
FormerGrant of patent is intended
Status updated on  08.11.2023
FormerExamination is in progress
Status updated on  05.10.2019
FormerRequest for examination was made
Status updated on  02.02.2018
FormerThe international publication has been made
Status updated on  11.11.2016
Most recent event   Tooltip01.11.2024Lapse of the patent in a contracting state
New state(s): RO, SK		published on 04.12.2024 [2024/49]
Applicant(s)For all designated states
Cyberdyne Inc.
2-2-1 Gakuen Minami
Tsukuba-shi, Ibaraki 305-0818 / JP
For all designated states
University of Tsukuba
1-1-1, Tennodai
Tsukuba-shi, Ibaraki 305-8577 / JP
[2018/10]
Inventor(s)01 / SANKAI, Yoshiyuki
c/o University of Tsukuba
1-1-1, Tennodai
Tsukuba-shi, Ibaraki 305-8577 / JP
 [2018/10]
Representative(s)Hoefer & Partner Patentanwälte mbB
Pilgersheimer Straße 20
81543 München / DE
[2018/10]
Application number, filing date16789529.126.04.2016
[2018/10]
WO2016JP63114
Priority number, dateJP2015009428801.05.2015         Original published format: JP 2015094288
[2018/10]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016178393
Date:10.11.2016
Language:JA
[2016/45]
Type: A1 Application with search report 
No.:EP3289868
Date:07.03.2018
Language:EN
[2018/10]
Type: B1 Patent specification 
No.:EP3289868
Date:24.01.2024
Language:EN
[2024/04]
Search report(s)International search report - published on:JP10.11.2016
(Supplementary) European search report - dispatched on:EP26.11.2018
ClassificationIPC:A01K29/00, A01K15/02
[2023/44]
CPC:
A01K15/02 (EP,US); C12M21/08 (US); A01K15/027 (EP,US);
A61B5/1105 (US); A61B5/1128 (US); A61H3/008 (US);
A63B22/0235 (US); C12M3/00 (EP,US); A01K29/005 (EP,US) (-)
Former IPC [2018/10]A01K67/00, A01K15/02, C12M3/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VORRICHTUNG ZUR KULTIVIERUNG VON NERVENZELLEN[2023/45]
English:NERVE-CELL CULTURING APPARATUS[2023/45]
French:APPAREIL DE CULTURE DE CELLULES NERVEUSES[2023/45]
Former [2018/10]VORRICHTUNG ZUR BEWERTUNG DER VERBESSERUNG EINER MODELLTIERFUNKTION UND VORRICHTUNG ZUR KULTIVIERUNG VON NERVENZELLEN
Former [2018/10]MODEL-ANIMAL FUNCTIONAL-IMPROVEMENT EVALUATION APPARATUS AND NERVE-CELL CULTURING APPARATUS
Former [2018/10]APPAREIL D'ÉVALUATION D'AMÉLIORATION FONCTIONNELLE D'ANIMAL MODÈLE ET APPAREIL DE CULTURE DE CELLULES NERVEUSES
Entry into regional phase01.12.2017Translation filed 
01.12.2017National basic fee paid 
01.12.2017Search fee paid 
01.12.2017Designation fee(s) paid 
01.12.2017Examination fee paid 
Examination procedure01.12.2017Examination requested  [2018/10]
01.12.2017Date on which the examining division has become responsible
24.06.2019Amendment by applicant (claims and/or description)
09.10.2019Despatch of a communication from the examining division (Time limit: M06)
20.04.2020Reply to a communication from the examining division
08.07.2020Despatch of a communication from the examining division (Time limit: M04)
17.11.2020Reply to a communication from the examining division
25.03.2021Despatch of a communication from the examining division (Time limit: M04)
04.08.2021Reply to a communication from the examining division
09.12.2021Despatch of a communication from the examining division (Time limit: M06)
17.06.2022Reply to a communication from the examining division
19.01.2023Despatch of a communication from the examining division (Time limit: M04)
26.05.2023Reply to a communication from the examining division
09.11.2023Communication of intention to grant the patent
19.12.2023Fee for grant paid
19.12.2023Fee for publishing/printing paid
19.12.2023Receipt of the translation of the claim(s)
Fees paidRenewal fee
30.04.2018Renewal fee patent year 03
30.04.2019Renewal fee patent year 04
31.03.2020Renewal fee patent year 05
30.04.2021Renewal fee patent year 06
31.03.2022Renewal fee patent year 07
31.03.2023Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.01.2024
BG24.01.2024
CZ24.01.2024
DK24.01.2024
EE24.01.2024
ES24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
LV24.01.2024
NL24.01.2024
PL24.01.2024
RO24.01.2024
SE24.01.2024
SK24.01.2024
SM24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
PT24.05.2024
[2024/49]
Former [2024/48]AT24.01.2024
BG24.01.2024
CZ24.01.2024
DK24.01.2024
EE24.01.2024
ES24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
LV24.01.2024
NL24.01.2024
PL24.01.2024
SE24.01.2024
SM24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
PT24.05.2024
Former [2024/47]AT24.01.2024
BG24.01.2024
DK24.01.2024
ES24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
LV24.01.2024
NL24.01.2024
PL24.01.2024
SE24.01.2024
SM24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
PT24.05.2024
Former [2024/37]AT24.01.2024
BG24.01.2024
ES24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
LV24.01.2024
NL24.01.2024
PL24.01.2024
SE24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
PT24.05.2024
Former [2024/36]AT24.01.2024
BG24.01.2024
ES24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
LV24.01.2024
NL24.01.2024
PL24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
PT24.05.2024
Former [2024/35]AT24.01.2024
BG24.01.2024
ES24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
NL24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
Former [2024/34]BG24.01.2024
FI24.01.2024
HR24.01.2024
LT24.01.2024
NL24.01.2024
NO24.04.2024
RS24.04.2024
GR25.04.2024
IS24.05.2024
Former [2024/33]LT24.01.2024
NL24.01.2024
NO24.04.2024
IS24.05.2024
Former [2024/32]NL24.01.2024
IS24.05.2024
Former [2024/31]NL24.01.2024
Documents cited:Search[XI]US2002157617  (REINKENSMEYER DAVID J [US], et al) [X] 1-7 * paragraphs [0041] - [0126]; figures 1-16 *[I] 8-13;
 [XI]EP2226006  (UNIV TSUKUBA [JP], et al) [X] 1-3,5-7 * paragraphs [0013] - [0151]; figures 1-18 * [I] 4
International search[Y]US2002157617  (REINKENSMEYER DAVID J [US], et al) [Y] 1-13 * , paragraphs [0041] to [0126]; fig. 1 to 4 *;
 [Y]JP2004147521  (TAIHO PHARMACEUTICAL CO LTD) [Y] 3 * , paragraphs [0047] to [0048] *;
 [A]JP2006320221  (KEIO GIJUKU, et al) [A] 1-13;
 [A]JP2008264509  (UNIV TSUKUBA) [A] 1-13;
 [Y]WO2012118143  (UNIV TSUKUBA [JP], et al) [Y] 5, 11 * , paragraphs [0046], [0070] to [0072]; fig. 1, 5 *;
 [Y]JP2013031425  (UNIV QINGHUA, et al) [Y] 8-13 * , paragraphs [0017] to [0025]; fig. 1 to 3 *;
 [A]JP2013094093  (SAKAI MEDICAL CO LTD)[A] 1-13;
 [Y]JP2014161587  (UNIV TSUKUBA) [Y] 1-13 * , paragraphs [0015] to [0032], [0109] to [0126]; fig. 1, 2, 16 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.